These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 20947723)
1. Changes to medicare part D: who benefits? DeMartino JK J Natl Compr Canc Netw; 2010 Sep; 8 Suppl 7():S4-6. PubMed ID: 20947723 [No Abstract] [Full Text] [Related]
2. Health reform accelerates changes in the pharmaceutical industry. Spatz ID Health Aff (Millwood); 2010 Jul; 29(7):1331-6. PubMed ID: 20606183 [TBL] [Abstract][Full Text] [Related]
3. Pharmaceuticals and medical devices: Medicare Part D. Issue brief. Steiner DJ Issue Brief Health Policy Track Serv; 2012 Dec; ():1-32. PubMed ID: 23297447 [No Abstract] [Full Text] [Related]
4. Pharmaceuticals and medical devices: Medicare Part D. Steiner DJ Issue Brief Health Policy Track Serv; 2013 Dec; ():1-32. PubMed ID: 24482890 [No Abstract] [Full Text] [Related]
5. Impact of cost sharing on prescription drugs used by Medicare beneficiaries. Goedken AM; Urmie JM; Farris KB; Doucette WR Res Social Adm Pharm; 2010 Jun; 6(2):100-9. PubMed ID: 20511109 [TBL] [Abstract][Full Text] [Related]
6. Understanding the effects of Medicare Part D from key stakeholders' perspectives: Important progress, but abundant research opportunities remain. Urmie JM; Doucette WR Res Social Adm Pharm; 2010 Jun; 6(2):85-9. PubMed ID: 20511107 [No Abstract] [Full Text] [Related]
7. Pharmaceuticals and medical devices: Medicare Part D. ; Steiner DJ Issue Brief Health Policy Track Serv; 2012 Jan; ():1-37. PubMed ID: 22403844 [No Abstract] [Full Text] [Related]
8. Pharmaceuticals and medical devices: Medicare Part D. End-of-year issue brief. Thomson Reuters/West Issue Brief Health Policy Track Serv; 2011 Jan; ():1-28. PubMed ID: 21374839 [No Abstract] [Full Text] [Related]
9. Assessing the impact of coverage gaps in the Medicare Part D drug benefit. Hudson N Find Brief; 2008 Apr; 11(3):1-3. PubMed ID: 18441611 [TBL] [Abstract][Full Text] [Related]
10. Cancer Care Under the Biden Administration. Dusetzina SB JAMA; 2021 Feb; 325(6):527-528. PubMed ID: 33560329 [No Abstract] [Full Text] [Related]
11. A model for reform. Medicare must be changed to survive; part D offers a solution. Turner GM Mod Healthc; 2013 May; 43(18):28-9. PubMed ID: 24044252 [No Abstract] [Full Text] [Related]
12. Doughnuts and Discounts - Changes to Medicare Part D under the Bipartisan Budget Act of 2018. Donohue JM; Huskamp HA N Engl J Med; 2018 May; 378(21):1957-1960. PubMed ID: 29791823 [No Abstract] [Full Text] [Related]
13. Time to fill the doughnuts--health care reform and Medicare Part D. Shrank WH; Choudhry NK N Engl J Med; 2011 Feb; 364(7):598-601. PubMed ID: 21247308 [No Abstract] [Full Text] [Related]
14. Impact of Medicare Part D on independent and chain community pharmacies in rural Illinois--A qualitative study. Bono JD; Crawford SY Res Social Adm Pharm; 2010 Jun; 6(2):110-20. PubMed ID: 20511110 [TBL] [Abstract][Full Text] [Related]
15. Changing health insurance trends. Iglehart JK N Engl J Med; 2002 Sep; 347(12):956-62. PubMed ID: 12239275 [No Abstract] [Full Text] [Related]
17. Medicare part D: ongoing challenges for doctors and patients. Jacobson G; Anderson G Annu Rev Med; 2010; 61():469-76. PubMed ID: 20059349 [TBL] [Abstract][Full Text] [Related]